A 3-Part First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Male Subjects
Phase of Trial: Phase I
Latest Information Update: 28 Sep 2017
At a glance
- Drugs Ichorcumab (Primary) ; Ichorcumab (Primary)
- Indications Thrombosis
- Focus Adverse reactions; First in man; Pharmacodynamics
- Sponsors Janssen Research & Development
- 22 Sep 2017 Status changed from recruiting to completed.
- 30 Nov 2016 Status changed from not yet recruiting to recruiting.
- 07 Nov 2016 New trial record